We recently published a list of Jim Cramer refers to a larger program behind the prices and breaks down these 7 actions. In this article, we are going to examine where REPORSION PHARMACEUTICALS, Inc. (NASDAQ: RXRX) stands against other actions of which Jim Cramer discusses.
In his last appearance on CNBC Squawk in the streetJim Cramer suggested that recent prices do not simply concern the economic lever effect. He referred to a deeper program in certain parts of the administration which goes beyond the commercial policy:
“There is a lot of sense that something will happen that will remove this. In fact, just because of what we have seen the other day with 10%, I do not see this at all. I think these are very different types of prices. I mean, it is a price where I think there are people with the administration who really finally has a change of diet.”
Read also: Jim Cramer reacts to the overvoltage of the surprise market and highlights 8 key actions And Jim Cramer questions the logic of the market and dissects these 7 key actions
Discussing the probability of a negotiated regulation between Washington and Beijing, Cramer expressed deep skepticism that China withdraws under pressure. Instead, he described Chinese leadership that had long prepared for confrontation:
“When the Chinese are back right now they are not, but I don't know. I think the Chinese have been ready for this since the first Trump. I think they are ready for prices. I think they are going to build coalitions around the world. I don't think they are not paper tigers. I think they are a strong country and they are ready for the fight.
To make our list of actions that Jim Cramer has spoken, we listed the actions he mentioned during Squawk of CNBC in the street broadcast on April 11.
For these actions, we have also mentioned the number of investors of hedge funds. Why are we interested in the stocks in which the hedge funds stacked? The reason is simple: our research has shown that we can surpass the market by imitating the main choices of stock of the best hedge funds. The strategy of our quarterly newsletter selects 14 shares with small capitalization and large capitalization each quarter and has rendered 373.4% since May 2014, beating its reference with 218 percentage points (See more details here).
Number of hedge holders: 21
A change in policy of the late FDA has drawn the attention to crammer as a revolutionary moment for the Biotechnology Society with small capitalization Recursion Pharmaceuticals, Inc. (Nasdaq: RXRX). Cramer considered this to be a deregular step, which could play directly in the Discovery Platform of drugs focused on the AI of Recursion. Here is what he said:
